Do you have an early-stage project or groundbreaking idea but need to learn the basic components of biomedical product development? Biomedical Innovation Program fastPACE is a four-week course that provides scientists with the basic knowledge and tools to initiate the innovation and commercialization process.
fastPACE is free. Registration is now open and seats are limited.
Sept. 26: Seminar and breakout sessions
Oct. 5, Oct. 12, Oct. 19: Webinars
Oct. 26: Team presentations
See the course syllabus
This course is designed for faculty, researchers, students, and industry scientists with an early stage idea or team with an idea. fastPACE instructors are experts from across the bioscience industry and academia with experience bringing healthcare technologies and therapeutics to market.
Teaching lead for Device, Diagnostic and Software track: Ann Demaree, M.B.A., vice president of marketing and business development, Cardiac Insight
Teaching lead for Drug Discovery track: Steve Runnels, M.B.A., former vice president of marketing and business development, Sigma AldrichThe program is modeled after the successful National Science Foundation I-Corps program and adopted from University of Michigan’s Fast Forward Medical Innovation program. fastPACE combines in-person and online experiential education to help researchers and clinicians learn the basic components of biomedical commercialization and prepare a successful business case to secure funding, partnerships and further research opportunities.
The Oregon Clinical and Translational Research Institute offers the program in collaboration with Technology Transfer and Business Development and the Oregon Bioscience Incubator.
Program coordinators, Melissa Mudd and Jonathan Jubera, are available to answer any questions.
Content experts: Steve Wittenbrock, SoMA Product Design; Dick Rylander, OHSU Executive-in-Residence; Charla Triplett, Future Brand Speck; Les Mace, Medical technology consultant; Wes Parker, Schwabe, Williamson, & Wyatt; Michael Roberts, OHSU Technology Transfer & Business Development; John Hoffman, Quality Management Resources; Richard Wynkoop, Vision 28; Joe Hooyboer, Cambia; Bill Newman, Northwest Technology Ventures; Nathan Lillegard, University of Oregon; Andrew Watson, OHSU Technology Transfer and Business Development; Steve Eck, OHSU Technology Transfer and Business Development; Alyssa Thomas, Allegiance Regulatory Consulting
